ARCHIVES

NCI To Recompete Drug Discovery Groups In 2003 As Program Nears Its 20th Year

This article is from The Cancer Letter archive.

Vol. 28 No. 44 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

Tuck To Direct Clinical Trials At Yale; Arceci Joins Hopkins.

October 13, 2000

In Brief: NIH Study Finds Intramural Program Tenures Few Minorities, Calls For Improvements

March 11, 1994

In Brief: Five Candidates Interview for NCI Job, Harris To Make Recommendation Within Month

May 2, 1980

Prevention Trials Should Get More Funding, Coltman Says.

May 18, 2001

PET Three Months After Therapy Provides Early Warning Of Need For Intervention

November 30, 2007